The European Heart Journal has issued an expression of concern for a
2014 2001 paper by Don Poldermans, the Dutch heart researcher who stepped down from his post at Erasmus University after being accused of misconduct.
The article, “Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery,” appeared in July and reported data from the DECREASE trial. Poldermans, who left Erasmus in 2011, has acknowledged failing to receive informed consent from some patients in one phase of the DECREASE study but denied having fabricated results.
According to the notice: Continue reading “Wide differences in the memories” prompt expression of concern for Poldermans paper
Just 48 hours after publishing an article by Graham Cole and Darrel Francis last week alleging that Don Poldermans‘ scientific misconduct led to the deaths of some 800,000 Europeans over the past five years by tainting clinical guidelines, the European Heart Journal unceremoniously pulled the paper from its website Friday.
Larry Husten at CardioBrief has been on top of the story. According to Husten: Continue reading Quickest withdrawal ever? Journal yanks paper alleging 800K deaths from Poldermans affair
Hiroaki Matsubara, a prominent cardiologist with five Expressions of Concern and two retractions for his CV, has another retraction.
As Larry Husten, who first reported the retraction at Forbes, notes, the notice for 2009’s “Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study,” which appeared in the European Heart Journal, says very little: Continue reading Study of blood pressure drug valsartan retracted